FDA clears Covidien's Solitaire revascularization device; St. Jude Medical, Stryker top list of most admired companies;

@FierceMedDev: Youngstown News, New motion-sensor technology eases debilitating pain of Boardman man. News via @vindicator. Story | Follow @FierceMedDev

> The FDA has cleared Covidien's ($COV) Solitaire FR revascularization device. The device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke. Covidien release

> St. Jude Medical ($STJ) and Stryker ($SYK) tied for No. 1 on this year's CNN Money Most Admired Companies list. Report

> Trinity Biotech has agreed to pay up to $13 million to buy Fiomi Diagnostics, a Swedish developer of kits used for confirming heart attacks. News

> Roche's Ventana Medical Systems has gotten the FDA's signoff for its Inform HER2 dual ISH DNA probe cocktail assay on the Ventana BenchMark Ultra automated slide staining platform. Ventana release

> Leesburg, VA-based K2M has received 510(k) clearance from the FDA to market the Santorini corpectomy cage systems. K2M release

And Finally... Researchers at the University of California-Berkeley and the Champalimaud Center for the Unknown in Portugal have shown that the brain is more flexible and trainable than people realize. The team's discovery may give rise to the development of thought-controlled prosthetic devices to help people with spinal cord injuries, amputations and other impairments. Release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.